Revisiting aid dependency for HIV programs in Sub-Saharan Africa.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
May 2019
Historique:
received: 12 08 2018
revised: 21 12 2018
accepted: 16 02 2019
pubmed: 2 4 2019
medline: 8 6 2019
entrez: 2 4 2019
Statut: ppublish

Résumé

The overall increase in global domestic HIV expenditure obscures the specific performances of many sub-Saharan Africa (SSA) countries in local resourcing of their HIV programs. In this study, we explored the pattern and correlates of domestic HIV expenditure in SSA. This is a cross-sectional ecological study. Data were obtained from the Joint United Nations Programme on HIV/AIDS, World Bank, and the World Health Organization. We included 30 countries with available country-reported HIV expenditures between 2012 and 2017. From the most recent data, we examined the domestic (public and private) HIV expenditure as percentage of the total HIV expenditure. Using Spearman's rho, we assessed the correlation between domestic expenditure as percentage of the total HIV expenditure and HIV prevalence, antiretroviral coverage, gross national income (GNI) per capita, domestic general government health expenditure (GGHE-D) as percentage of general government expenditure, and GGHE-D per capita. Significant correlates at bivariate level were included in a multivariate median regression model. The median domestic HIV expenditure as percentage of the total HIV expenditure was 24.9% (interquartile range [IQR]: 8.5-39.3%). In 15 of 30 (50%) countries, domestic HIV expenditure as percentage of the total HIV expenditure was ≤25%. In 23 of 30 (77%) countries, public source accounted for >75% of the domestic HIV expenditure. There was a significant positive correlation between domestic expenditure as percentage of total HIV expenditure and GNI per capita (r = 0.52, P = 0.003) and GGHE-D per capita (r = 0.494, P = 0.005). In the multivariate median regression model, only GNI per capita remained statistically significant (β = 0.006, P = 0.004). Some countries in SSA are still overly dependent on external support for their HIV response. Although increasing domestic HIV expenditure in these countries may require growth in the economy, governments can improve the fiscal space for HIV response by looking inward for innovative and sustainable funding mechanisms.

Identifiants

pubmed: 30933882
pii: S0033-3506(19)30052-6
doi: 10.1016/j.puhe.2019.02.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-60

Informations de copyright

Copyright © 2019 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Auteurs

B O Olakunde (BO)

National Agency for the Control of AIDS, Abuja, Nigeria. Electronic address: boolakunde@yahoo.com.

D A Adeyinka (DA)

Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, Canada; National AIDS & STIs Control Programme, Federal Ministry of Health, Abuja, Nigeria.

C E Ozigbu (CE)

National AIDS & STIs Control Programme, Federal Ministry of Health, Abuja, Nigeria; Department of Health Services Policy and Management, University of South Carolina, Columbia, USA.

T Ogundipe (T)

Department of Community and Family Medicine, Howard University Hospital, Washington DC, USA.

W N A Menson (WNA)

Ghana Health Service, Accra, Ghana.

J O Olawepo (JO)

School of Public Health, University of Nevada, Las Vegas, NV, USA; Caritas Nigeria, Abuja, Nigeria.

O A Olakunde (OA)

Ondo State Primary Health Care Development Board, Ondo, Nigeria.

E E Ezeanolue (EE)

Department of Pediatrics and Child Health, College of Medicine, University of Nigeria, Nsukka, Enugu, Nigeria; HealthySunrise Foundation, Las Vegas, NV, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH